← All stocks

Aktis Oncology, Inc.

AKTS No buying or selling
CIK 0002035832 #2335 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

10 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
MPM BIOVENTURES 2018, L.P.
10% owner
10,260,064
$252.01M
+2,903%
GADICKE ANSBERT
10% owner
10,260,064
$252.01M
+2,903%
Foley Todd
Director
4,235,403
$104.03M
EcoR1 Capital, LLC entity
Director
347,305
$8.53M
Vida Ventures II, LLC entity
10% owner
157,387
$3.87M
Kim Helen Susan
Director
157,387
$3.87M
Segal Lloyd Mitchell
Director
19,631
$482.18K
Herrmann Ken
Director
0
$0.00
Ron-Bigger Shulamit
Chief Operating Officer
0
$0.00
Czibere Akos
Chief Medical Officer
0
$0.00

No percentages here. This company's share count has moved by a factor of 58.4 over the window, from 915,261 to 53,446,222 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 0
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 12 Jan 2026